Please provide your email address to receive an email when new articles are posted on . A bipolar conduction system pacing implantable cardioverter defibrillator lead met safety and effectiveness ...
GALWAY, Ireland, March 23, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, received U.S. Food and Drug Administration (FDA) approval for an expanded ...
Conduction-system pacing (CSP) was put to the test in two randomized trials of patients requiring cardiac resynchronization therapy (CRT) for left bundle branch block (LBBB)—the HeartSync-LBBP and ...
World’s First Leadless Left Bundle Branch Area Pacing Implant Utilizing EBR Systems’ WiSE CRT System
SUNNYVALE, Calif.--(BUSINESS WIRE)--EBR Systems, Inc., developer of the world’s only wireless cardiac pacing system for heart failure, today announced that Professor Pascal Defaye, Head of Rhythmology ...
Medtronic "Conduction System Pacing" Expanded Indication Now Includes Left Bundle Branch Area Pacing in Addition to His-Bundle Pacing for Patients with Slow Heart Rates Medtronic is the first and only ...
A dedicated bipolar implantable cardioverter-defibrillator (ICD) lead for conduction system pacing (CSP) performed well in a first-in-human multicenter study. Placement of the novel UltiSynq CSP ICD ...
SUNNYVALE, Calif.--(BUSINESS WIRE)--EBR Systems, Inc., developer of the world’s smallest, wireless, implantable device for cardiac pacing, today announced the U.S. Food and Drug Administration has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results